RxSight (NASDAQ: RXST - Get Free Report) and Organigram Global (NASDAQ: OGI - Get Free Report) are b

Organigram Global Inc. (OGI:CA) Discusses Strategic Priorities, Growth Initiatives, and Insights fro

Organigram Global NASDAQ: OGI outlined a strategy centered on protecting its Canadian market positio

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organig

KORU Medical Systems (NASDAQ: KRMD - Get Free Report) and Organigram Global (NASDAQ: OGI - Get Free

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organig

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (“Organigram” or the “Company”) today announ

Sanity Group integration marks the next phase of Organigram’s global growth strategyFinn Age Hänsel

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (“Organigram” or the “Comp

OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estima

Organigram Global NASDAQ: OGI reported record third-quarter fiscal 2026 revenue and adjusted EBITDA,

Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's

OrganiGram Holdings (NASDAQ:OGI) reported quarterly sales of $76.413 million which beat the analyst

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organi

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organi

Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Cana

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organi

Organigram's disappointing Q2 earnings could be a direct result of its record harvests overwhelming

Organigram Global Inc. (OGI:CA) Q2 2026 Earnings Call Transcript

Organigram Global Inc. (NASDAQ:OGI) reported weaker second-quarter fiscal 2026 results as declining

Organigram reports weak Q2 fiscal 2026 results due to vape and pre-roll sales decline, but expects i

OrganiGram (OGI) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus

Organigram Global NASDAQ: OGI reported a weaker second quarter for fiscal 2026, with management attr

OrganiGram Holdings (NASDAQ:OGI) reported quarterly losses of $(0.01) per share which met the analys

OrganiGram Holdings (NASDAQ:OGI) reported quarterly sales of $43.597 million which missed the analys

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organi

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organi

Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a le

This launch reflects Organigram's focus on differentiated innovation while leveraging the scale

Organigram Global Inc. ("Organigram" or the "Company") today announced the expansion

Organigram Global Inc. (OGI) shares rose after a $65.2 million private placement investment from Bri

Organigram stock surges after announcing proposed acquisition of Sanity Group, aiming to establish a

Accretive Acquisition of Sanity Group Establishes Organigram as a Global Pure Play Cannabis Company

https://www.marijuanamoment.net/trumps-marijuana-executive-order-details-leaked-ahead-of-announcemen

Trump is expected to sign an executive order reclassifying cannabis to Schedule III, easing federal

https://abcnews.go.com/Politics/trump-sign-executive-order-reclassifying-marijuana-officials/story?i

OrganiGram Holdings (NASDAQ:OGI) reported quarterly losses of $(0.20) per share which missed the ana

Investors are prepping for this week's earnings reports which include homebuilders, several appa

The stock prices of major cannabis companies like skyrocketed n premarket trading on Friday, followi

President Donald Trump is reportedly planning to advocate for a significant relaxation of federal re